Photodynamic therapy (PDT) refers to a technique that enables the destruction of a target tissue by the administration of an inactive, light sensitive agent (a "photosensitiser") and the local application of light, in the presence of oxygen. The photosensitiser absorbs light (which is generated by a laser) and transfers this energy to the surrounding tissues, triggering cell destruction. The procedure is done under a general anaesthetic and requires you to stay in hospital for 2 days.
Several clinical trials have already been done for the treatment of localised prostate cancer by PDT both as a first line treatment and for recurrent prostate cancer following radiotherapy.
PDT is suitable for men with early prostate cancer.
At present clinical trials continue. We can provide more information if you would like to know more.